[go: up one dir, main page]

TW330205B - A process for preparing loracarbef monohydrate - Google Patents

A process for preparing loracarbef monohydrate

Info

Publication number
TW330205B
TW330205B TW085102100A TW85102100A TW330205B TW 330205 B TW330205 B TW 330205B TW 085102100 A TW085102100 A TW 085102100A TW 85102100 A TW85102100 A TW 85102100A TW 330205 B TW330205 B TW 330205B
Authority
TW
Taiwan
Prior art keywords
preparing
loracarbef monohydrate
monohydrate
loracarbef
compound
Prior art date
Application number
TW085102100A
Other languages
English (en)
Inventor
Carl Henning William
R Stout Theodore
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of TW330205B publication Critical patent/TW330205B/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D463/00—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D463/10—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D463/14—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hetero atoms directly attached in position 7
    • C07D463/16—Nitrogen atoms
    • C07D463/18—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof
    • C07D463/20—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D463/22—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen further substituted by nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
TW085102100A 1995-03-01 1996-02-24 A process for preparing loracarbef monohydrate TW330205B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/396,948 US5580977A (en) 1995-03-01 1995-03-01 Process for preparing loracarbef monohydrate

Publications (1)

Publication Number Publication Date
TW330205B true TW330205B (en) 1998-04-21

Family

ID=23569249

Family Applications (1)

Application Number Title Priority Date Filing Date
TW085102100A TW330205B (en) 1995-03-01 1996-02-24 A process for preparing loracarbef monohydrate

Country Status (28)

Country Link
US (1) US5580977A (zh)
EP (1) EP0729959B1 (zh)
JP (1) JPH11501032A (zh)
KR (1) KR19980702666A (zh)
CN (1) CN1061349C (zh)
AR (1) AR002709A1 (zh)
AT (1) ATE184006T1 (zh)
AU (1) AU694639B2 (zh)
BR (1) BR9607308A (zh)
CA (1) CA2213812A1 (zh)
CO (1) CO4700429A1 (zh)
CZ (1) CZ272897A3 (zh)
DE (1) DE69603995T2 (zh)
DK (1) DK0729959T3 (zh)
ES (1) ES2135165T3 (zh)
GR (1) GR3031947T3 (zh)
HU (1) HUP9702151A3 (zh)
IL (1) IL117228A (zh)
NO (1) NO308471B1 (zh)
NZ (1) NZ304534A (zh)
PE (1) PE28097A1 (zh)
PL (1) PL322111A1 (zh)
RU (1) RU2160261C2 (zh)
SI (1) SI0729959T1 (zh)
TR (1) TR199700877T1 (zh)
TW (1) TW330205B (zh)
WO (1) WO1996026942A1 (zh)
ZA (1) ZA961341B (zh)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2309350C (en) 1997-11-12 2007-04-03 Mitsubishi Chemical Corporation Purine derivatives and medicaments comprising the same as active ingredient
KR100747106B1 (ko) 1999-05-11 2007-08-08 미쯔비시 가가꾸 가부시끼가이샤 퓨린 유도체 이수화물, 이를 유효성분으로 함유하는 의약및 이의 제조 중간체
PE20011061A1 (es) 2000-02-01 2001-11-20 Procter & Gamble Cristalizacion selectiva del acido 3-piridil-1-hidroxi-etiliden-1,1-bisfosfonico sodio como el hemipentahidrato o el monohidrato
US6562974B2 (en) 2000-02-01 2003-05-13 The Procter & Gamble Company Process for making geminal bisphosphonates
US20060205938A1 (en) * 2002-11-21 2006-09-14 Yatendra Kumar Monohydrate solvates of loracarbef

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3531481A (en) * 1969-04-21 1970-09-29 Lilly Co Eli Method for manufacture of crystalline cephalosporin
US3502663A (en) * 1969-04-21 1970-03-24 Lilly Co Eli Crystalline cephalosporin,method for its manufacture
US4775751A (en) * 1985-06-03 1988-10-04 Eli Lilly & Company Process for cephalexin hydrochloride alcoholates
EG18529A (en) * 1987-10-06 1993-04-30 Lilly Co Eli Process for preparing b-lactam hydrate
CA2002596A1 (en) * 1988-11-14 1990-05-14 Thomas M. Eckrich Hydrates of b-lactam antibiotic
CA2002597C (en) * 1988-11-14 1999-03-23 Thomas M. Eckrich Solvates of b-lactam antibiotic
US4977257A (en) * 1988-11-14 1990-12-11 Eli Lilly And Company DMF solvates of a β-lactam antibiotic
US5374719A (en) * 1993-06-04 1994-12-20 Eli Lilly And Company Process for converting loracarbef dihydrate to loracarbef monohydrate
US5352782A (en) * 1993-06-04 1994-10-04 Eli Lilly And Company Process for preparing crystalline β-lactam monohydrate
US5399686A (en) * 1993-06-04 1995-03-21 Eli Lilly And Company Loracarbef isopropanolate and a process for converting loracarbef isopropanolate to loracarbef monohydrate

Also Published As

Publication number Publication date
CZ272897A3 (cs) 1998-01-14
DK0729959T3 (da) 1999-12-13
NZ304534A (en) 1998-09-24
IL117228A0 (en) 1996-06-18
NO308471B1 (no) 2000-09-18
DE69603995D1 (de) 1999-10-07
AR002709A1 (es) 1998-04-29
EP0729959A1 (en) 1996-09-04
DE69603995T2 (de) 2000-01-20
CO4700429A1 (es) 1998-12-29
JPH11501032A (ja) 1999-01-26
NO973835D0 (no) 1997-08-20
TR199700877T1 (xx) 1998-02-21
MX9706606A (es) 1997-11-29
PE28097A1 (es) 1997-08-20
AU694639B2 (en) 1998-07-23
RU2160261C2 (ru) 2000-12-10
PL322111A1 (en) 1998-01-05
ATE184006T1 (de) 1999-09-15
GR3031947T3 (en) 2000-03-31
SI0729959T1 (en) 1999-12-31
HUP9702151A2 (hu) 1998-07-28
CN1182429A (zh) 1998-05-20
CN1061349C (zh) 2001-01-31
US5580977A (en) 1996-12-03
WO1996026942A1 (en) 1996-09-06
IL117228A (en) 2000-12-06
ZA961341B (en) 1997-08-20
AU5174296A (en) 1996-09-18
NO973835L (no) 1997-08-20
CA2213812A1 (en) 1996-09-06
KR19980702666A (ko) 1998-08-05
ES2135165T3 (es) 1999-10-16
HUP9702151A3 (en) 2001-01-29
BR9607308A (pt) 1997-11-25
EP0729959B1 (en) 1999-09-01

Similar Documents

Publication Publication Date Title
KR950702206A (ko) 감미제로 유용한 신규 화합물과 그 제조방법(compounds useful as sweetening agents and process for their preparation)
HUT66660A (en) Intermediates for producing 9-[(substituted glicyl)-amido]-6-demetyl-6-deoxy-tetracyclines and pharmaceutical compositions containing them
TNSN92022A1 (fr) Procede de preparation de nouveaux derives de l'indole
IE810654L (en) Azetidinone derivatives.
MX9804046A (es) 6-0-metil eritromicina d y proceso para hacerla.
MY116862A (en) New processes for preparing pesticidal intermediates
AU7556591A (en) Microbial production of a novel compound 7,10-dihydroxy-8-octadecenoic acid from oleic acid
TW330205B (en) A process for preparing loracarbef monohydrate
NO940018D0 (no) Fremgangsmaate for fremstilling av svovelholdige imidazolderivater
DE69737376D1 (de) Verfahren zur Synthese einer Oxonolverbindung
MY110724A (en) Process for converting loracarbef dihydrate to loracarbef monohydrate
HU9401673D0 (en) Loracarbe-isopropanolate and a process for converting it to monohydrate
CA2145181A1 (en) Process for preparing 1-2,-substituted-5-formylimidazoles
HUT61262A (en) Process for reacting hydroxy compound of small molecular mass with carboxylic acid halgenide
GR3033386T3 (en) Vitamin d derivative and process for producing the same.
PT842924E (pt) Intermediarios de piridina uteis na sintese de agonistas de receptores beta-adrenergicos
GB9602866D0 (en) Novel process
NZ332245A (en) Substituted benzo-oxazolol carboxylic acid derivatives, process for their production and medicaments containing them
MX9603450A (es) Procedimiento para la obtencion de aminotriazolinas substituidas.
MY120806A (en) Improved process for preparing pharmaceutically valuable norbenzomorphane derivatives.
GB9516143D0 (en) Improved chemical synthesis
GR3023031T3 (en) Process for producing imidazole derivative
DE3461281D1 (en) +/- 2-((3,4-methylenedioxy)phenethyl)-5-((3-carboxamido-4-hydroxy)-alpha-hydroxybenzyl)pyrrolidines, pharmaceutical compositions containing them, process for their production and intermediates therefor
EP0844236A4 (en) METHOD FOR PRODUCING CARBAMOYL METHYL URINE DERIVATIVES
FR2697521B1 (fr) Procédé de synthèse du picolinate d'éthyle.